Inhaled nitric oxide and neuroprotection in preterm infants.

Abstract	Although inhaled nitric oxide-mediated decreases in chronic lung disease and severe intraventricular hemorrhage/periventricular leukomalacia undoubtedly contribute to improved neurodevelopmental outcomes, inhaled nitric oxide has an independent neuroprotective effect. Although these data are encouraging, additional studies are required before recommending the routine use of inhaled nitric oxide for neuroprotection in preterm infants.
Authors	Jeremy D Marks, Michael D Schreiber
Journal	Clinics in perinatology (Clin Perinatol) Vol. 35 Issue 4 Pg. 793-807, viii (Dec 2008) ISSN: 1557-9840 [Electronic] United States
PMID	19026341 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References	Neuroprotective Agents Nitric Oxide
Topics	Administration, Inhalation Central Nervous System Diseases (prevention & control) Heart (drug effects) Humans Infant, Newborn Infant, Premature Lung (drug effects) Nervous System (drug effects, growth & development) Neuroprotective Agents (administration & dosage, therapeutic use) Nitric Oxide (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!